Bibliography
- Suri SS, Fenniri H, Singh B. Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007;2(1):1-6
- Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9(8):615-27
- Otilia MK, Israel R, Hayat O. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomed NBM 2005;1:193-212
- Krombach F, Münzing S, Allmeling AM, Cell size of alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997;105(5):1261-3
- Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69
- Adamopoulos IE, Sabokbar A, Wordsworth BP, Synovial fluid macrophages are capable of osteoclast formation and resorption. J Pathol 2006;208:35-43
- Schett G. Review: immune cells and mediators of inflammatory arthritis. Autoimmunity 2008;41:224-9
- Sebastiaan MB, Viviana C-J, Neeltje AK, HIV-1 and the macrophages. Future Virol 2011;6(2):187-208
- Freedman BD, Liu QH, Del Corno M, HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages. Immunol Res 2003;27:261-76
- Gras G, Chretien F, Vallat-Decouvelaere AV, Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol 2003;13:211-22
- Weinberg JB, Matthews TJ, Cullen BR, Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 1991;174:1477-82
- Orenstein JM, Meltzer MS, Phipps T, Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988;62:2578-86
- Marechal V, Prevost MC, Petit C, Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 2001;75:11166-77
- Pruthi J, Mehra NK, Jain NK. Macrophages targeting of amphotericin B loaded mannosylated carbon nanotubes. J Drug Target 2012;20(7):593-604
- Banerjee A, Roychoudhury J, Ali N, Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine. J Antimicrob Chemother 2008;61:103-10
- Kunjachan S, Gupta S, Dwivedi AK, Chitosan based macrophage mediated drug targeting for the treatment of experimental visceral leishmaniasis. J Microencapsul 2011;28(4):301-10
- Kumar PV, Asthana A, Dutta T, Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 2006;14(8):546–
- Friedman BA, Vaddi K, Preston C, Comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived b-glucocerebrosidase: implications for clinical efficacy in treatment of gaucher disease. Blood 1999;93(9):2807-16
- Furbish FS, Steer CJ, Krett NL, Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation. Biochim Biophys Acta 1981;673:425-34
- BethAnn F, Kris V, Constance P, A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived b-glucocerebrosidase: implications for clinical efficacy in treatment of gaucher disease. Blood 1999;93(9):2807-16
- Shimizu T, Ohkawara A, Nishihira J, Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996;381:199-202
- Watanabe H, Shimizu T, Nishihira J, Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J Biol Chem 2004;279:1676-83
- Bach JP, Rinn B, Meyer B, Role of MIF in inflammation and tumorigenesis. Oncology 2008;75:127-33
- Taylor M, Bezouska K, Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 1992;267:1719-26
- Ezekowitz R, Williams D, Koziel H, Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991;351:155-8
- Taylor ME, Conary JT, Lennartz MR, Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 1990;265(121):56-62
- Ezekowitz RA, Sastry K, Bailly P, Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 1990;172:1785-94
- Largent BL, Walton KM, Hoppe CA, Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces. J Biol Chem 1984;259:1764-69
- Liu J, Teng L, Liu C, Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro. J Drug Target 2009;17:216-24
- Schmieder A, Schledzewski K, Michel J, Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. Int J Cancer 2011;129:122-32
- Zhang-Hoover J, Sutton A, Van Rooijen N, A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis. Immunology 2000;101:501-11
- Turville S, Wilkinson J, Cameron P, The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J Leukoc Biol 2003;74:710-18
- Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol 2003;33:483-93
- Song EH, Manganiello MJ, Chow YH, In vivo targeting of alveolar macrophages via RAFT-based glycopolymers. Biomaterials 2012;33:6889-97
- Wattendorf U, Coullerez G, Voros J, Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir 2008;24:11790-802
- Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol 2004;40(12):869-76
- Aouadi M, Tesz GJ, Nicoloro SM, Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009;458(7242):1180-4
- Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, Folate receptor 1 is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 2009;69:9395-03
- Ross JF, Wang H, Behm FG, Folate receptor type 1 is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 1999;85:348-57
- Van Der Heijden JW, Oerlemans R, Dijkmans BAC, Folate receptor 1 as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients. Arthritis Rheum 2009;60:12-21
- Rollett A, Reiter T, Nogueira P, Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. Int J Pharm 2012;427:460-6
- Wilkinson K, ElKhoury J. Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. Int J Alzheimers Dis 2012;2012:1-10
- Graversen JH, Svendsen P, Dagbes-Hansen F, Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the anti-inflammatory potency of dexamethasone. Mol Ther 2012;20(8):1550-8
- Wang X, Guo J, Chen T, Multi-walled carbon nanotubes induce apoptosis via mitochondrial pathway and scavenger receptor. Toxicol In Vitro 2012;26:799-806
- Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-37
- Pechkovsky DV, Prasse A, Kollert F, Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 2010;137:89-101
- Nahar M, Jain NK. Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles. Pharm Res 2009;26:2588-98
- Nimje N, Agarwal A, Saraogi GK, Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target 2009;17:777-87
- Prakash J, Beljaars L, Harapanahalli AK, Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor. Int J Cancer 2010;126:1966-81
- Yoo MK, Park IY, Kim IY, Superparamagnetic iron oxide nanoparticles coated with mannan for macrophage targeting. J Nanosci Nanotechnol 2008;8:5196-202
- Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 2010;9:1095-107
- Makino K, Yamamoto N, Higuchi K, Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids Surf Biointerfaces 2003;27:33-9
- Makino K, Nakajima T, Shikamura M, Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effect of molecular weight and composition of PLGA on release of rifampicin. Colloids Surf Biointerfaces 2004;36:35-42
- Tomoda K, Makino K. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Colloids Surf B Biointerfaces 2007;55:115-24
- Hwang SM, Kim DD, Chung SJ, Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis. J Control Release 2008;129:100-6
- Chono S, Tanino T, Seki T, Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol 2007;59:75-80
- Wijagkanalan W, Kawakami S, Takenaga M. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 2008;125:121-30
- Wijagkanalan W, Kawakami S, Higuchi Y, Intratracheally instilled mannosylated cationic liposome/NF kB decoy complexes for effective prevention of LPS-induced lung inflammation. J Control Release 2011;149:42-50
- Singodia D, Verma A, Verma RK, Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomed Nanotech Biol Med 2012;8:468-77
- Ahsan F, Rivas IP, Khan MA, Targeting to macrophages: role of physiochemical properties of particulate carriers-liposomes and microspheres- on the phagocytosis by macrophages. J Control Release 2002;79:29-40
- Nahar M, Dubey V, Mishra D, In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis. J Drug Target 2010;18(2):93-105
- Mishra V, Gupta U, Jain NK. Surface-engineered dendrimers: a solution for toxicity issues. J Biomater Sci Polym Ed 2009;20(2):141-66
- Mishra V, Gupta U, Jain NK. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie 2010;65(12):891-5
- Jain K, Kesharwani P, Gupta U, Dendrimer: let's meet the challenge. Int J Pharm 2010;394:122-42
- Jain K, Kesharwani P, Gupta U, A review of glycosylated carriers for drug delivery. Biomaterials 2012;33(16):4166-86
- Dutta T, Garg M, Jain NK. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur J Pharm Sci 2008;34:181-9
- Gaikwad SY, Jagtap AG, Indle AD, Antimetastatic efficacy of niosomal pentoxifylline and its combination with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm 2000;15(6):605-15
- Gude RP, Jadhav MG, Rao SGA, Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm 2002;17:183-9
- Singh G, Dwivedi H, Saraf SK, Niosomal delivery of isoniazid-development and characterization. Trop J Pharm Res 2011;10(2):203-10
- Iijima S. Helical microtubules of graphite carbon. Nature 1991;354:56-8
- Jain AK, Mehra NK, Lodhi N, Carbon nanotubes and their toxicity. Nanotoxicology 2007;1(3):167-97
- Mehra NK, Jain AK, Lodhi N, Challenges in the use of carbon nanotubes for biomedical application. Crit Rev Ther Drug Carr Syst 2008;25(2):169-206
- Jain AK, Mehra NK, Lodhi N, Galactose conjugated multi walled carbon nanotubes: development and characterization. Nanomed Nanotech Biol Med 2009;5(4):432-42
- Lodhi N, Mehra NK, Jain NK. Dexamethasone conjugated multi walled carbon nanotubes: Development and characterization. J Drug Target 2012; In press; DOI: 10.3109/1061186X.2012.729213
- Prajapati VK, Awasthi K, Gautam S, Targeted killing of leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. J Antimicrob Chemother 2011;66:874-9
- Yeeprae W, Kawakami S, Yamashita F, Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release 2006;114:193-201
- Pangburn TO, Georgiou K, Bates FS, Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression. Langmuir 2012;28(35):12816-30
- Kim Y, Tewari M, Pajerowski JD, Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release 2009;134(2):132-40
- Meng FH, Zhong ZY, Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 2009;10(2):197-209
- Blanazs A, Armes SP, Ryan AJ. Self-assembled block copolymer aggregates: from micelles to vesicles and their biological applications. Macromol Rapid Commun 2009;30(4-5):267-77
- Liu G, Ma S, Li S, The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes. Biomaterials 2010;31:7575-85
- Vasdekis AE, Scott EA, O'Neil CP, Precision intracellular delivery based on optofluidic polymersome rupture. ACS Nano 2012;6(9):7850-7
- Sanchez-Brunete JA, Dea MA, Rama S, Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres. Antimicrob Agents Chemother 2004;48(9):3246-52
- Chono S, Tanino T, Seki T, Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Release 2008;127:50-8
- Tsujimuraa K, Ikehara Y, Nagata T, Induction of anti-tumor immune responses with oligomannose-coated liposomes targeting to peritoneal macrophages. 2nd Vaccine Global Congress, Boston 2008. Procedia Vaccinol 2009;1:127-34
- Etzerodt A, Maniecki MB, Graversen JH, Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release 2012;160:72-80
- Glucksam-Galnoy Y, Zor T, Margalit R. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a proinflammatory response. J Control Release 2012;160:388-93
- Kagan VE, Tyurina YY, Tyurin VA, Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol Lett 2006;165:88-100
- VanHandel M, Alizadeh D, Zhang L, Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model. J Neuroimmunol 2009;208:3-9
- Montes-Fonseca SL, Orrantia-Borunda E, Aguilar-Elguezabal A, Cytotoxicity of functionalized carbon nanotubes in J774A macrophages. Nanomed Nanotech Biol Med 2012;8:853-5
- Zhang T, Tang M, Kong L, Comparison of cytotoxic and inflammatory responses of pristine and functionalized multi walled carbon nanotubes in RAW 264.7 mouse macrophages. J Hazard Mater 2012;219-220:203-12